我要投票 博奥生物在基因检测行业中的票数:107
· 外 推 电 报 ·
2025-03-04 03:31:54 星期二

【博奥生物是哪个国家的品牌?】

博奥生物是什么牌子?「博奥生物」是 博奥生物集团有限公司 旗下著名品牌。该品牌发源于北京市,由创始人程总在2000年期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力博奥生物品牌出海!通过在本页面挂载博奥生物品牌的产品链接和联系邮箱,可以提高博奥生物产品曝光!跨境电商爆单神器,目前只要100元/年哦~

成立于2000年,清华控股旗下,生命科学研究和健康产业的企业,打造集健康产品/健康管理和医疗康复于一体的大健康产业版块。

博奥生物集团有限公司于2000年9月30日在国务院、发改委、科技部、教育部、卫生部和北京市领导大力支持下,以清华大学为依托、联合华中科技大学、中国医学科学院、军事医学科学院注册成立,是生命科学研究和健康产业的国有创新型高科技企业。公司总部位于北京,现有员工2000多人,研发、生产、运营和服务基地超过10万平方米。

公司以生物芯片为核心技术平台,拥有研发、生产、销售以及全国第三方独立医学检验所服务为一体的大医学完整产业链,并响应国家关于“预防为主”的健康方针,将现代医学与中国传统医学紧密结合,打造出集健康产品、健康管理和医疗康复于一体的大健康产业版块。迄今,博奥生物在国内已经形成了北京、上海、重庆、成都等大型产业化基地,并形成了以北京博奥晶典生物技术有限公司为核心的产业化平台。

成立18年来,博奥生物依托清华大学和生物芯片北京国家工程研究中心雄厚的研发实力,已成功开发出生物芯片及相关试剂耗材、仪器设备、软件数据库、生命科学服务、临床检验服务、健康管理等系列数十项具有自主知识产权的产品和服务。公司先后获得德国TÜV莱茵公司颁发的ISO9001、ISO13485、ISO14000、ISO18000、ISO27000质量管理体系认证证书、美国组织相容性及遗传学协会(ASHI)认证证书和中国合格评定国家认可委员会实验室认证证书,其产品获得CFDA、CE 、GS、CB等国内外各类认证证书100余项。至今,博奥生物已在全球获得专利授权300余项,专利转化率较高。

因其优良的研发、生产、营销和服务团队,以及生物芯片技术平台和高标准的质保体系,博奥生物除与国内近百家三甲医院、高校、公安和司法机构建立了战略合作,还与罗氏应用科学、罗氏诊断、昂飞、热电等国际生命科学和医学诊断领域的公司建立了伙伴关系,产品及服务出口北美、欧洲、亚洲等三十多个国家和地区。其中,诊断用生物芯片及相关仪器产品已进入英国、德国、瑞典、意大利、西班牙、奥地利、瑞士、葡萄牙、芬兰、丹麦、日本、新加坡等国家的数百家医院。

英文翻译:Founded in 2000, Tsinghua holdings, a life science research and health industry enterprise, has created a large health industry section integrating health products / health management and medical rehabilitation. On September 30, 2000, with the support of the State Council, the national development and Reform Commission, the Ministry of science and technology, the Ministry of education, the Ministry of health and the leaders of Beijing Municipality, Bo'ao biological Group Co., Ltd. was established on the basis of Tsinghua University and registered with Huazhong University of science and technology, the Chinese Academy of Medical Sciences and the Academy of Military Medical Sciences. It is a state-owned innovative high-tech enterprise in life science research and health industry. The company is headquartered in Beijing, with more than 2000 employees and over 100000 square meters of R & D, production, operation and service bases. With biochip as the core technology platform, the company has a complete industrial chain of large-scale medicine integrating R & D, production, sales and the services of the national third-party independent medical laboratory. In response to the national health policy of "prevention first", the company closely combines modern medicine with traditional Chinese medicine to create a large-scale health industry integrating health products, health management and medical rehabilitation Industry forum. So far, Boao biology has formed large-scale industrialization bases in China, such as Beijing, Shanghai, Chongqing, Chengdu, and formed an industrialization platform with Beijing Boao Jingdian Biotechnology Co., Ltd. as the core. Since its establishment 18 years ago, relying on the strong R & D strength of Tsinghua University and biochip Beijing National Engineering Research Center, BOCOG bio has successfully developed dozens of products and services with independent intellectual property rights, including biochip and related reagent consumables, instruments and equipment, software database, life science services, clinical testing services, health management, etc. The company has successively obtained ISO9001, ISO13485, ISO14000, ISO18000, ISO27000 quality management system certification issued by Germany t Ü V Rhine company, Ashi certification and laboratory certification issued by China National Accreditation for conformity assessment. Its products have obtained more than 100 kinds of certification certificates at home and abroad, such as CFDA, CE, GS, CB, etc. So far, Bo'ao biology has obtained more than 300 patent authorizations in the world, with a high patent conversion rate. Due to its excellent R & D, production, marketing and service team, as well as the biochip technology platform and high standard quality assurance system, Boao biology has established strategic cooperation with nearly 100 top three hospitals, universities, public security and judicial institutions in China, as well as partnerships with companies in international life science and medical diagnosis fields such as Roche Applied Science, Roche diagnosis, onfe, thermoelectricity, etc Products and services are exported to more than 30 countries and regions in North America, Europe and Asia. Among them, diagnostic biochip and related instrument products have entered hundreds of hospitals in Britain, Germany, Sweden, Italy, Spain, Austria, Switzerland, Portugal, Finland, Denmark, Japan, Singapore and other countries.

本文链接: https://www.waitui.com/brand/126365a18.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

跃岭股份:杰思金材将成为公司第一大股东,股票明起复牌

36氪获悉,跃岭股份公告,公司控股股东、实际控制人林仙明、林万青、林信福、林申茂、林平、林斌与北京杰思金材科技有限公司签署《股份转让协议》,林氏家族合计转让的股份数量为62,875,020股(占上市公司股份总数的24.5606%),转让完成后,杰思金材将成为公司第一大股东,公司实际控制人将变更为王冠然。公司股票自2025年3月4日起复牌。

2小时前

深圳:推动深圳数据交易所打造国家级数据交易所,发放“语料券”

36氪获悉,深圳市工业和信息化局印发《深圳市加快打造人工智能先锋城市行动计划(2025—2026年)》。加快构建行业语料集。充分利用深圳产业丰富优势,持续构建行业语料集,支撑垂类模型训练。打造高价值垂类数据集,重点培育医疗、教育、交通等高价值垂类数据集,汇聚建成3PB中文语料数据。培育建设重点行业可信数据空间,鼓励行业企业、互联网平台企业联合研究机构和行业组织,试点建设医疗等行业可信数据空间,释放行业数据价值。推动深圳数据交易所打造国家级数据交易所,发放“语料券”,促进人工智能语料共享和交易。

2小时前

美股大型科技股盘前多数上涨,特斯拉涨超3%

36氪获悉,美股大型科技股盘前多数上涨,截至发稿,特斯拉涨超3%,Arm涨超1%,奈飞涨0.91%,亚马逊涨0.88%,Meta涨0.77%,谷歌涨0.72%,微软涨0.49%;英伟达跌0.23%,苹果跌0.11%。

2小时前

热门中概股美股盘前多数下跌,理想汽车跌超8%

36氪获悉,热门中概股美股盘前多数下跌,截至发稿,理想汽车跌超8%,小鹏汽车跌超5%,蔚来、新东方跌超2%,京东跌超1%,网易跌0.63%,百度跌0.12%;阿里巴巴、拼多多涨超1%。

2小时前

四连板恒为科技:公司昇腾Deepseek一体机尚在样机研发推广阶段

36氪获悉,恒为科技公告,股票价格偏离公司基本面较大,存在估值较高风险。后续公司股票价格存在大幅上涨后下跌的风险。公司昇腾Deepseek一体机在AI服务器上安装部署Deepseek大模型并进行调优,目前市场上有多家公司宣布推出一体机,公司的产品竞争力尚未得到市场验证,目前尚在样机研发推广阶段,没有形成销售订单,也没有产生收入,公司与深度求索无业务往来。

2小时前

本页详细列出关于赛福基因的品牌信息,含品牌所属公司介绍,赛福基因所处行业的品牌地位及优势。
咨询